Memorial Sloan Kettering Nassau (Limited Protocol Activities)
Memorial Sloan Kettering Nassau (Limited Protocol Activities)
Uniondale, New York, United States120 results ยท Page 1 of 5
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study of Hospital-at-Home for People Receiving Tarlatamab | Neoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, respiratory system disorder, respiratory tract neoplasm, small cell lung carcinoma | Recruiting | Not applicable | 2026-10-09 | NCT06957314 | |
| Radiation Therapy in Combination With Durvalumab for People With Pancreatic Cancer | pancreatic adenocarcinoma | Active, not recruiting | Phase 1 / Phase 2 | 2026-10-09 | NCT03245541 | |
| A Study of Avutometinib (VS-6766) and Defactinib in People With Mesonephric Gynecologic Cancer | Mesonephric Gynecologic Cancer | Active, not recruiting | Phase 2 | 2026-10-08 | NCT05787561 | |
| A Study of Fianlimab, Cemiplimab, and Ipilimumab in People With Melanoma | Advanced Melanoma | Recruiting | Phase 2 | 2026-10-07 | NCT06594991 | |
| A Study on Adding Precisely Targeted Radiation Therapy (Stereotactic Body Radiation Therapy) to the Usual Treatment Approach (Drug Therapy) in People With Breast Cancer | Neoplasms by Site, Skin and Connective Tissue Diseases, breast cancer, breast disorder, breast neoplasm, estrogen-receptor positive breast cancer, neoplasm, skin disorder | Recruiting | Phase 2 | 2026-10-02 | NCT05534438 | |
| Adding Certolizumab to Chemotherapy + Nivolumab in People Who Have Lung Cancer That Can Be Treated With Surgery | Neoplasms by Site, Thoracic Neoplasms, lung cancer, lung disorder, lung neoplasm, neoplasm, respiratory system disorder, respiratory tract neoplasm | Recruiting | Phase 2 | 2026-10-02 | NCT04991025 | |
| A Study of Melphalan With or Without Siltuximab in People With Multiple Myeloma Having an Autologous Stem Cell Transplant | Blood Protein Disorders, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, cardiovascular disorder, hematologic disorder, hemorrhagic disease, immune system disorder, immunoproliferative disorder, lymphoproliferative syndrome, monoclonal gammopathy, neoplasm, plasma cell neoplasm, vascular disorder, vascular hemostatic disease | Recruiting | Phase 2 | 2026-10-01 | NCT06679829 | |
| A Study of Lenvatinib, Pembrolizumab, and Fulvestrant in People With Breast Cancer | Neoplasms by Site, Skin and Connective Tissue Diseases, breast disorder, breast neoplasm, neoplasm, skin disorder | Active, not recruiting | Phase 1 / Phase 2 | 2026-09-28 | NCT06110793 | |
| A Study Comparing Personalized Radiation Therapy With Standard Radiation Therapy in People With HPV-Positive Throat Cancer | human papillomavirus-related squamous cell carcinoma | Recruiting | Phase 3 | 2026-09-24 | NCT06563479 | |
| A Registry for People With Lung Cancer | Neoplasms by Site, Thoracic Neoplasms, lung cancer, lung disorder, lung neoplasm, neoplasm, respiratory system disorder, respiratory tract neoplasm | Recruiting | Not stated | 2026-09-24 | NCT06424327 | |
| A Study of Pembrolizumab With Trastuzumab and Chemotherapy in People With Esophagogastric Cancer | Digestive System Diseases, Digestive System Neoplasms, Esophageal Neoplasms, Head and Neck Neoplasms, Neoplasms by Site, digestive system disorder, digestive system neoplasm, esophageal cancer, esophageal disorder, gastric adenocarcinoma, neoplasm | Recruiting | Phase 2 | 2026-09-24 | NCT06123338 | |
| A Study of Additional Chemotherapy After Surgery for People With Malignant Peritoneal Mesothelioma | Neoplasms by Histologic Type, Neoplasms by Site, Thoracic Neoplasms, adenoma, epithelial neoplasm, lung disorder, lung neoplasm, malignant mesothelioma, malignant peritoneal mesothelioma, mesothelial neoplasm, mesothelioma, neoplasm, peritoneal mesothelioma, pleural neoplasm, respiratory system disorder, respiratory tract neoplasm | Recruiting | Phase 2 | 2026-09-24 | NCT06057935 | |
| A Study of an Alternative Treatment Approach (Preoperative Radiotherapy, Then Mastectomy, Then Immediate Reconstruction Surgery) in People With T4 Breast Cancer | Neoplasms by Site, Skin and Connective Tissue Diseases, breast cancer, breast disorder, breast neoplasm, invasive breast carcinoma, neoplasm, skin disorder | Recruiting | Phase 1 | 2026-09-24 | NCT05412225 | |
| A Study of Cadonilimab Combined With Chemotherapy in People With Gastric or Gastroesophageal Junction Cancer | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, digestive system disorder, digestive system neoplasm, gastric cancer, gastric neoplasm, neoplasm, stomach disorder | Recruiting | Phase 2 | 2026-09-23 | NCT07631000 | |
| A Study Using Human Papillomavirus (HPV) DNA Testing to Detect HPV-Related Oropharyngeal Cancer (OPC) | Head and Neck Neoplasms, Neoplasms by Site, Otorhinolaryngologic Neoplasms, Pharyngeal Diseases, Stomatognathic Diseases, neoplasm, otorhinolaryngologic disease | Active, not recruiting | Not stated | 2026-09-23 | NCT05814549 | |
| A Study of NALIRIFOX in Combination With Radiation Therapy in People With Pancreatic Ductal Adenocarcinoma (PDAC) | pancreatic ductal adenocarcinoma | Recruiting | Phase 2 | 2026-09-17 | NCT05851924 | |
| A Study of BIO 300 and Thoracic Radiation Therapy in People With Non-Small Cell Lung Cancer and Interstitial Lung Disease | Neoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, interstitial lung disease, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasm | Recruiting | Phase 2 | 2026-09-16 | NCT07323732 | |
| A Study of Mirdametinib in Combination With Palbociclib in People With Liposarcoma | Neoplasms by Histologic Type, Neoplasms, Adipose Tissue, Neoplasms, Connective and Soft Tissue, Well Differentiated Liposarcoma, liposarcoma, myxoid liposarcoma, neoplasm, sarcoma | Recruiting | Phase 1 / Phase 2 | 2026-09-16 | NCT06843967 | |
| A Study of Health-Related Quality of Life in People With Multiple Myeloma Receiving Daratumumab or Lenalidomide | Blood Protein Disorders, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, cardiovascular disorder, hematologic disorder, hemorrhagic disease, immune system disorder, immunoproliferative disorder, lymphoproliferative syndrome, monoclonal gammopathy, neoplasm, plasma cell neoplasm, vascular disorder, vascular hemostatic disease | Active, not recruiting | Phase 2 | 2026-09-15 | NCT04497961 | |
| A Study of SX-682 in Combination With Proton Craniospinal Irradiation (pCSI) in People With Leptomeningeal Disease | Neoplasms by Site, central nervous system cancer, neoplasm, nervous system disorder, tumor of meninges | Recruiting | Phase 1 | 2026-09-11 | NCT07814352 | |
| Osimertinib Alone or With Chemotherapy for EGFR-Mutant Lung Cancers | Neoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasm | Recruiting | Phase 2 | 2026-09-11 | NCT04410796 | |
| A Study of Zanubrutinib, Obinutuzumab, and Sonrotoclax in People With Mantle Cell Lymphoma | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, mantle cell lymphoma, neoplasm | Not yet recruiting | Phase 2 | 2026-09-10 | NCT07799220 | |
| A Study of Vemurafenib and Obinutuzumab Compared to Cladribine and Rituximab in People With Hairy Cell Leukemia (HCL) | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, hairy cell leukemia, hematologic disorder, immune system disorder, immunoproliferative disorder, leukemia, lymphatic system disorder, lymphoproliferative syndrome, neoplasm | Recruiting | Phase 2 | 2026-09-09 | NCT06561360 | |
| A Study of Ruxolitinib and Duvelisib in People With Lymphoma | Disease Attributes, Hemic and Lymphatic Diseases, Leukemia, Large Granular Lymphocytic, Neoplasms by Histologic Type, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence, T-cell leukemia, T-cell non-Hodgkin lymphoma, T-cell prolymphocytic leukemia, hematologic disorder, immune system disorder, immunoproliferative disorder, leukemia, lymphatic system disorder, lymphoid leukemia, lymphoma, lymphoproliferative syndrome, neoplasm, prolymphocytic leukemia | Recruiting | Phase 1 | 2026-09-09 | NCT05010005 | |
| A Study of Ruxolitinib in Combination With Abemaciclib for the Treatment of Myelofibrosis | Myelofibrosis Due to and Following Polycythemia Vera | Recruiting | Phase 1 | 2026-09-03 | NCT05714072 |